Literature DB >> 6605483

Linkage between surface immunoglobulin and cytoskeleton of B lymphocytes may involve Gc protein.

M Petrini, D L Emerson, R M Galbraith.   

Abstract

The membrane immunoglobulin (MIg) of B lymphocytes is thought to have an important role in antigen recognition and cellular activation. In common with many membrane glycoproteins, MIg moves extensively in the lipid bilayer, and after binding of specific antisera displays lateral mobility with patch and cap formation. This phenomenon appears to involve the cytoskeleton, particularly the actin that is present in the cell membrane of B lymphocytes and aggregates beneath capped immunoglobulin. Recently, it has been reported that the isolation of MIg results in co-purification of actin and an unknown protein of molecular weight (MW) approximately 56,000 (refs 7, 8). We now demonstrate that this component displays physicochemical and immunological properties indistinguishable from those of Gc (group-specific component). In addition, evidence is presented which suggests that this vitamin D3-binding protein is involved in the linkage between MIg and actin, and may therefore be important in signal transduction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605483     DOI: 10.1038/306073a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  27 in total

1.  Upregulation of vitamin D binding protein (Gc-globulin) binding sites during neutrophil activation from a latent reservoir in azurophil granules.

Authors:  Stephen J DiMartino; Glenda Trujillo; Lauren A McVoy; Jianhua Zhang; Richard R Kew
Journal:  Mol Immunol       Date:  2006-11-20       Impact factor: 4.407

2.  Binding of GC (VDBP) to membranes of human B lymphocytes following stripping of extant protein.

Authors:  M Petrini; A Allegrini; F Ambrogi; P Valentini; A Sabbatini; P Arnaud; R M Galbraith
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

3.  1,25-Dihydroxycholecalciferol inhibits the cochemotactic activity of Gc (vitamin D binding protein).

Authors:  M Petrini; A Azzarà; G Carulli; B Grassi; F Ambrogi; R M Galbraith
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

4.  Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.

Authors:  Tait D Shanafelt; Matthew T Drake; Matthew J Maurer; Cristine Allmer; Kari G Rabe; Susan L Slager; George J Weiner; Timothy G Call; Brian K Link; Clive S Zent; Neil E Kay; Curtis A Hanson; Thomas E Witzig; James R Cerhan
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

5.  Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein.

Authors:  F F Safadi; P Thornton; H Magiera; B W Hollis; M Gentile; J G Haddad; S A Liebhaber; N E Cooke
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

6.  Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit.

Authors:  P J Goldschmidt-Clermont; H Van Baelen; R Bouillon; T E Shook; M H Williams; A E Nel; R M Galbraith
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 7.  Interactions between surface molecules and the cytoskeleton in the lymphocyte.

Authors:  J C Bennett
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

8.  Uptake and degradation of vitamin D binding protein and vitamin D binding protein-actin complex in vivo in the rat.

Authors:  S Dueland; R Blomhoff; J I Pedersen
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

9.  Inhibition of human natural killer activity by antiserum against vitamin D-binding protein, a group-specific component (Gc).

Authors:  T Chujo; T Machii; S Tagawa; H Kuratsune; E Ueda; H Kimura; T Kitani
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

10.  Distribution of the 1,25 dihydroxy-vitamin D3 receptor in the bursa of Fabricius of chicken.

Authors:  M Petrini; F Bianchi; A Dolfi; M Lupetti
Journal:  Experientia       Date:  1991-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.